Use of venetoclax in combination with hypomethylating agents in patients with acute myeloid leukemia relapsing after allogeneic hematopoietic stem cell transplantation

被引：0
|
作者：
Ozturk, C. [1 ]
Sahin, U. [2 ]
Seval, G. C. [1 ]
Bozdag, S. C. [1 ]
Toprak, S. K. [1 ]
Yuksel, M. K. [1 ]
Topcuoglu, P. [1 ]
Ozcan, M. [1 ]
Gurman, G. [1 ]
Ilhan, O. [1 ]
Arslan, O. [1 ]
机构：
[1] Ankara Univ, Ankara, Turkey
[2] Medicana Int Ankara Hosp, Ankara, Turkey
来源：
BONE MARROW TRANSPLANTATION | 2022年 / 57卷 / SUPPL 1期
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
P432
引用
收藏
页码：335 / 336
页数：2
相关论文
共 50 条
  • [21] Treatment of myeloid malignancies relapsing after allogeneic hematopoietic stem cell transplantation with venetoclax and hypomethylating agents—a retrospective multicenter analysis on behalf of the German Cooperative Transplant Study Group
    Esther Schuler
    Eva-Maria Wagner-Drouet
    Salem Ajib
    Gesine Bug
    Martina Crysandt
    Sabine Dressler
    Andreas Hausmann
    Daniela Heidenreich
    Klaus Hirschbühl
    Matthias Hoepting
    Edgar Jost
    Jennifer Kaivers
    Stefan Klein
    Michael Koldehoff
    Lambros Kordelas
    Oliver Kriege
    Lutz P. Müller
    Christina Rautenberg
    Judith Schaffrath
    Christoph Schmid
    Daniel Wolff
    Rainer Haas
    Martin Bornhäuser
    Thomas Schroeder
    Guido Kobbe
    Annals of Hematology, 2021, 100 : 959 - 968
  • [22] FACTORS ASSOCIATED WITH ACUTE MYELOID LEUKEMIA RELAPSING AFTER ALLOGENEIC STEM CELL TRANSPLANTATION
    Jose Dominguez-Garcia, Juan
    Martin Sanchez, Guillermo
    Colorado Araujo, Maria de las Mercedes
    Sanchez Escamilla, Miriam
    Cerezo Martin, Juan Manuel
    Montes Gaisan, Carmen
    Ocio San Miguel, Enrique Maria
    Bermudez Rodriguez, Maria Aranzazu
    BONE MARROW TRANSPLANTATION, 2023, 58 (SUPP1) : 170 - 171
  • [23] Allogeneic Hematopoietic Stem Cell Transplantation for Older Patients With Acute Myeloid Leukemia
    Levin-Epstein, Rebecca
    Oliai, Caspian
    Schiller, Gary
    CURRENT TREATMENT OPTIONS IN ONCOLOGY, 2018, 19 (12)
  • [24] Allogeneic Hematopoietic Stem Cell Transplantation for Older Patients With Acute Myeloid Leukemia
    Rebecca Levin-Epstein
    Caspian Oliai
    Gary Schiller
    Current Treatment Options in Oncology, 2018, 19
  • [25] Second allogeneic hematopoietic stem cell transplantation in patients with acute leukemia relapsed after allogeneic hematopoietic stem cell transplantation
    Choi, Yunsuk
    Choi, Eun-Ji
    Lee, Jung-Hee
    Lee, Kyoo-Hyung
    Jo, Jae-Cheol
    Park, Han-Seung
    Lee, Yoo Jin
    Seol, Miee
    Lee, Young-Shin
    Kang, Young-Ah
    Jeon, Mijin
    Lee, Je-Hwan
    CLINICAL TRANSPLANTATION, 2021, 35 (03)
  • [26] Treatment of myeloid malignancies relapsing after allogeneic hematopoietic stem cell transplantation with venetoclax and hypomethylating agents-a retrospective multicenter analysis on behalf of the German Cooperative Transplant Study Group
    Schuler, Esther
    Wagner-Drouet, Eva-Maria
    Ajib, Salem
    Bug, Gesine
    Crysandt, Martina
    Dressler, Sabine
    Hausmann, Andreas
    Heidenreich, Daniela
    Hirschbuehl, Klaus
    Hoepting, Matthias
    Jost, Edgar
    Kaivers, Jennifer
    Klein, Stefan
    Koldehoff, Michael
    Kordelas, Lambros
    Kriege, Oliver
    Mueller, Lutz P.
    Rautenberg, Christina
    Schaffrath, Judith
    Schmid, Christoph
    Wolff, Daniel
    Haas, Rainer
    Bornhaeuser, Martin
    Schroeder, Thomas
    Kobbe, Guido
    ANNALS OF HEMATOLOGY, 2021, 100 (04) : 959 - 968
  • [27] Correction to: Treatment of myeloid malignancies relapsing after allogeneic hematopoietic stem cell transplantation with venetoclax and hypomethylating agents—a retrospective multicenter analysis on behalf of the German Cooperative Transplant Study Group
    Esther Schuler
    Eva-Maria Wagner-Drouet
    Salem Ajib
    Gesine Bug
    Martina Crysandt
    Sabine Dressler
    Andreas Hausmann
    Daniela Heidenreich
    Klaus Hirschbühl
    Matthias Hoepting
    Edgar Jost
    Jennifer Kaivers
    Stefan Klein
    Michael Koldehoff
    Lambros Kordelas
    Oliver Kriege
    Lutz P. Müller
    Christina Rautenberg
    Judith Schaffrath
    Christoph Schmid
    Daniel Wolff
    Rainer Haas
    Martin Bornhäuser
    Thomas Schroeder
    Guido Kobbe
    Annals of Hematology, 2021, 100 : 2141 - 2142
  • [28] Efficacy of the combination of venetoclax and hypomethylating agents in relapsed/refractory acute myeloid leukemia
    Aldoss, Ibrahim
    Yang, Dongyun
    Aribi, Ahmed
    Ali, Haris
    Sandhu, Karamjeet
    Al Malki, Monzr M.
    Mei, Matthew
    Salhotra, Amandeep
    Khaled, Samer
    Nakamura, Ryotaro
    Snyder, David
    O'Donnell, Margaret
    Stein, Anthony S.
    Forman, Stephen J.
    Marcucci, Guido
    Pullarkat, Vinod
    HAEMATOLOGICA, 2018, 103 (09) : E404 - E407
  • [29] Hypomethylating agents for the treatment of relapsed acute myeloid leukemia after allogeneic blood stem cell transplantation: A single center experience
    Sciume, Mariarita
    Saporiti, Giorgia
    Tagliaferri, Elena
    Fracchiolla, Nicola
    Grifoni, Federica
    Levati, Giorgia
    Baldini, Luca
    Onida, Francesco
    BONE MARROW TRANSPLANTATION, 2019, 54 : 488 - 489
  • [30] HYPOMETHYLATING AGENTS FOR THE TREATMENT OF RELAPSED ACUTE MYELOID LEUKEMIA AFTER ALLOGENEIC BLOOD STEM CELL TRANSPLANTATION: A SINGLE CENTER EXPERIENCE
    Sciume, M.
    Soverini, G.
    Saporiti, G.
    Tagliaferri, E.
    Fracchiolla, N. S.
    Reda, G.
    Grifoni, F.
    Onida, F.
    Cortelezzi, A.
    HAEMATOLOGICA, 2017, 102 : 161 - 161
12345